Rossari Biotech has received approval from Board of Directors for capacity expansion by 13,000 MTPA. The said expansion is expected to be completed by the 4th Quarter of FY 2025-26 (in phased manner). The investment required for expansion is Rs 95 crore. This project is intended to accommodate new product lines. It aligns with market demand forecasts and enhances the competitive edge in the domestic and export markets.
Rossari Biotech is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products.
| Company Name | CMP |
|---|---|
| BASF India | 3651.95 |
| Tata Chemicals | 804.85 |
| SRF | 2551.40 |
| Pidilite Inds. | 1364.45 |
| Deepak Nitrite | 1751.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: